Cannabidiol Diabetes Research
The term diabetes refers to a group of metabolic diseases related to high blood sugar.
Type I diabetes occurs when the body is unable to produce insulin (a natural hormone that helps the body absorb sugar).
Type II diabetes occurs when a body does not respond normally to the natural insulin produced.
Recent cannabidiol diabetes studies have tested CBD and other cannabinoids as potential medications for treating diabetes and the results were encouraging in terms of efficacy and apparent lack of any statistically significant long-term side effects. Many studies concluded that Cannabidiol had a positive effect on a wide range of metabolic disorders (with a focus on diabetes), as CBD was shown to have some kind of mild “regulating” effect on the bodies of diabetes sufferers..
Additionally, this regulating effect seems to counteract several “dysregulating” effects that some metabolic diseases cause to the human body. More specifically, CBD has been shown to protect against diabetes-induced blindness by preserving a delicate chemical balance, encouraging the activity of an enzyme known as glutamine synthetase, which helps protect our retinal neurons. Also, Cannabidiol seems to alleviate albuminuria, a pathological condition that is strongly associated with diabetic nephropathy (a serious progressive kidney disease that is caused by longstanding diabetes).
Perhaps one of the most deciding factors in evaluating Cannabidiol’s efficiency as a diabetes medication is the fact that it seems to help in both type I and type II diabetes cases. This means that whether people have diabetes from early in their lives or whether they acquired it later on, Cannabidiol seems to assist in alleviating the symptoms and counteracting the causes.
In numerous cannabidiol diabetes studies, CBD-treated animals (mostly mice) were shown to have reduced diabetes symptoms, as long as they were not obese. This indicates that the efficacy of Cannabidiol to prevent and alleviate diabetes symptoms seems to be drastically diminished for overweight or obese individuals.
Based on these scientific findings that point out how Cannabidiol seems to lower the incidence as well as the severity of diabetes, many medical patents have emerged, aiming to patent the use of CBD in diabetes medicine. However, most of these patents are still pending as many studies on Cannabidiol and diabetes are not yet complete and the exact mechanism with which Cannabidiol affects diabetes is not yet fully understood.
Cannabidiol Diabetes PubMed Articles
Other Cannabidiol Diabetes Articles
- Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
Want to learn more about CBD?
Sign up below for our mailing list to get CBD news delivered right to your email inbox. We deliver the latest news and the occasional giveaway or promotion for our loyal readers.